| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/31/2001 | US6267955 Mononuclear phagocytes and their use to promote axonal regeneration |
| 07/31/2001 | CA2186641C Body fluid filtration device and application thereof |
| 07/31/2001 | CA2107553C Monoclonal antibodies to stem cell factor receptors |
| 07/31/2001 | CA2024667C Process for preparing a concentrate of blood coagulation factor viii-von willebrand factor complex from total plasma |
| 07/28/2001 | CA2297448A1 Improved inhibition of graft versus host disease |
| 07/26/2001 | WO2001053825A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 07/26/2001 | WO2001053518A2 Method of assessing the viability of a cell |
| 07/26/2001 | WO2001053506A2 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | WO2001053505A2 Herpes virus strains for gene therapy |
| 07/26/2001 | WO2001053490A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | WO2001053489A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | WO2001053467A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | WO2001053465A1 Human embryoid body-derived cells |
| 07/26/2001 | WO2001053462A1 Liver tissue source |
| 07/26/2001 | WO2001053461A1 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053324A2 Novel haptotactic peptides |
| 07/26/2001 | WO2001052890A1 Heat shock/stress protein complexes as vaccines against neurodegenerative disorders |
| 07/26/2001 | WO2001052878A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 07/26/2001 | WO2001052877A1 Compositions and methods to treat neurodegenerative disorders |
| 07/26/2001 | WO2001052871A1 Preparation and xenotransplantation of porcine islets |
| 07/26/2001 | WO2001052870A1 Treatment of congestive heart failure by pretreated autologous blood |
| 07/26/2001 | WO2001052667A2 Pet food composition for treating helicobacter species in pets |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2001052639A1 Use of pro-apoptotic factors in treatment of atherosclerosis |
| 07/26/2001 | WO2001034206A8 Nucleic acid-containing complex |
| 07/26/2001 | WO2001021766A9 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 07/26/2001 | WO2001017535A3 Enriched fraction from a porcine liver extract for treating human diseases |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2001000784A3 Compound derived from an offset orf of the ice gene |
| 07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |
| 07/26/2001 | WO2000047238A9 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | US20010009904 Process of delivering a polynucleotide to a cell via the vascular system |
| 07/26/2001 | US20010009903 Roasting process using far infrared radiation, microorganism fermentation to produce peroxide lipid thereby improving antitumor activity |
| 07/26/2001 | US20010009772 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 07/26/2001 | US20010009681 Methods of use for dietary compositions comprising lactoferrin and colostrum |
| 07/26/2001 | US20010009680 Such as various cancers, by administering low molecular weight compounds of following properties: extractable from bile of an animal, stimulates monocytes and macrophages, modulates tumor necrosis factor production, not endotoxin |
| 07/26/2001 | US20010009670 Parenterally administering large liposomes comprised of phospholipids substantially free of sterol, where the liposomes pick-up cholesterol |
| 07/26/2001 | US20010009669 Inactive flavivirus such as tick-born encephalitis (TBE) virus, an immunogenic component bonded to the flavivirus or adsorbed therewith |
| 07/26/2001 | DE19961141A1 Pharmazeutische Zusammensetzung aus Spinnengiften sowie deren Herstellung und Verwendung zur Behandlung von Tumorerkrankungen The pharmaceutical composition of spider venoms as well as their preparation and use for the treatment of tumor diseases |
| 07/26/2001 | DE10001169A1 New regulatory sequences from the fascin gene, useful for providing dendritic cell-specific expression of e.g. antigens, e.g. for vaccination against tumors and infections |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398343A1 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | CA2398239A1 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 07/26/2001 | CA2397931A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 07/26/2001 | CA2397927A1 Liver tissue source |
| 07/26/2001 | CA2397833A1 Novel haptotactic peptides |
| 07/26/2001 | CA2397783A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | CA2397324A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2395855A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | CA2297277A1 Cellular preparations |
| 07/25/2001 | EP1118660A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 07/25/2001 | EP1118659A1 Expression systems for functional nucleic acid expression |
| 07/25/2001 | EP1117791A2 Cancer associated antigens and uses therefor |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117776A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 07/25/2001 | EP1117767A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 07/25/2001 | EP1117765A2 Stem cells bearing an fgf receptor on the cell surface |
| 07/25/2001 | EP1117764A1 Primate embryonic stem cells with compatible histocompatibility genes |
| 07/25/2001 | EP1117762A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 07/25/2001 | EP1117679A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | EP1117438A1 Tie2 antagonist antibodies |
| 07/25/2001 | EP1117431A1 Control of acidosis |
| 07/25/2001 | EP1117430A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 07/25/2001 | EP1117414A1 Reduction of oxidative stress factors |
| 07/25/2001 | EP1117413A1 Transplantation of neural cells for the treatment of chronic pain or spasticity |
| 07/25/2001 | EP0577605B1 G protein-coupled glutamate receptors |
| 07/25/2001 | CN1305495A Peptide |
| 07/25/2001 | CN1304988A Mussel oil and its preparing process and application |
| 07/25/2001 | CN1304770A Heart-nourishing Chinese angelica root pill |
| 07/25/2001 | CN1304769A Blood-cleaning pill |
| 07/25/2001 | CN1304767A Plaster for treating infantile parotitis and its preparing process |
| 07/25/2001 | CN1304763A Medicine for treating scleroderma and its preparing process |
| 07/25/2001 | CN1304761A Regenerating medicine for skin injury and its preparing process |
| 07/25/2001 | CN1304760A Plaster for treating ostalgia and its preparing process |
| 07/25/2001 | CN1304755A Kidney-nourishing pill and its preparing process |
| 07/25/2001 | CN1304754A Health-preserving capsule |
| 07/25/2001 | CN1304751A Scrophularia capsule and its preparing process |
| 07/25/2001 | CN1304744A Chinese medicine for curing hepatitis B and cirrhosis ascites |
| 07/25/2001 | CN1304743A Medicine for treating injury |
| 07/25/2001 | CN1304732A Chinese patent medicine for treating hyperosteogeny |
| 07/25/2001 | CN1304731A Exterior-applied Chinese patent medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
| 07/25/2001 | CN1304729A Method for infecting mouse with pylorospirobacillus |
| 07/25/2001 | CN1304728A Soft yolk oil capsule |
| 07/25/2001 | CN1304702A Nutritive health-care beverage and its preparing process |
| 07/25/2001 | CN1068789C Tuberculosis treating medicine and its compounding process |
| 07/25/2001 | CN1068788C Anticancer and pain-releving paster |
| 07/25/2001 | CN1068786C Medicine for treating bone fracture and its preparing process |
| 07/25/2001 | CN1068784C External used medicinal liquor for preventing and curing multiple diseases |
| 07/25/2001 | CN1068783C Ointment for anti-inflammatory and curing burn and preparation method thereof |
| 07/25/2001 | CN1068781C Chinese medicine of spraying-applying dual puropose mailnly for treating burn and scald preparation method thereof |
| 07/24/2001 | US6265556 Nucleotide sequences coding mammalian polypeptide associated with immune response and cell propagation; for the detection of modulators of apoptosis |
| 07/24/2001 | US6265390 Methods for expressing nucleic acid sequences using nucleic acid constructs comprising hypoxia response elements |
| 07/24/2001 | US6265218 Introducing promoter and heterologous dna encoding a product into plasmid containing antibiotic resistance selection marker, amplifying, using restriction enzymes to form two fragments, cyclizing to form separate plasmids |
| 07/24/2001 | US6265189 Expressing polypeptide in cell culture; insert gene into viral expression vector, transform cells, recover preferential polypeptide |